{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:53:26Z","timestamp":1790643206056,"version":"4.1.0"},"reference-count":25,"publisher":"American Diabetes Association","issue":"7","license":[{"start":{"date-parts":[[2019,6,20]],"date-time":"2019-06-20T00:00:00Z","timestamp":1560988800000},"content-version":"vor","delay-in-days":49,"URL":"http:\/\/www.diabetesjournals.org\/content\/license"}],"funder":[{"name":"Swedish Government and the County Councils Concerning Economic Support of Research and Education of Doctors","award":["ALFGBG-427301"],"award-info":[{"award-number":["ALFGBG-427301"]}]},{"name":"Swedish Heart and Lung Foundation","award":["2015-0438"],"award-info":[{"award-number":["2015-0438"]}]},{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"crossref","award":["2013-5187 [SIMSAM]"],"award-info":[{"award-number":["2013-5187 [SIMSAM]"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"crossref","award":["2013-4236"],"award-info":[{"award-number":["2013-4236"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Swedish Council for Health, Working Life and Welfare","award":["2013-0325"],"award-info":[{"award-number":["2013-0325"]}]}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2019,7,1]]},"abstract":"<jats:sec>\n                  <jats:title>OBJECTIVE<\/jats:title>\n                  <jats:p>Low weight has been associated with increased mortality risks in type 1 diabetes. We aimed to investigate the importance of weight and weight gain\/loss in the Swedish population diagnosed with type 1 diabetes.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESEARCH DESIGN AND METHODS<\/jats:title>\n                  <jats:p>Patients with type 1 diabetes (n = 26,125; mean age 33.3 years; 45% women) registered in the Swedish National Diabetes Registry from 1998 to 2012 were followed from the first day of study entry. Cox regression was used to calculate risk of death from cardiovascular disease (CVD), major CVD events, hospitalizations for heart failure (HF), and total deaths.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESULTS<\/jats:title>\n                  <jats:p>Population mean BMI in patients with type 1 diabetes increased from 24.7 to 25.7 kg\/m2 from 1998 to 2012. Over a median follow-up of 10.9 years, there were 1,031 deaths (33.2% from CVD), 1,460 major CVD events, and 580 hospitalizations for HF. After exclusion of smokers, patients with poor metabolic control, and patients with a short follow-up time, there was no increased risk for mortality in those with BMI &amp;lt;25 kg\/m2, while BMI &amp;gt;25 kg\/m2 was associated with a minor increase in risk of mortality, major CVD, and HF. In women, associations with BMI were largely absent. Weight gain implied an increased risk of mortality and HF, while weight loss was not associated with higher risk.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONCLUSIONS<\/jats:title>\n                  <jats:p>Risk of major CVD, HF, CVD death, and mortality increased with increasing BMI, with associations more apparent in men than in women. After exclusion of factors associated with reverse causality, there was no evidence of an obesity paradox.<\/jats:p>\n               <\/jats:sec>","DOI":"10.2337\/dc18-1446","type":"journal-article","created":{"date-parts":[[2019,5,3]],"date-time":"2019-05-03T02:44:10Z","timestamp":1556851450000},"page":"1297-1304","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":93,"title":["BMI, Mortality, and Cardiovascular Outcomes in Type 1 Diabetes: Findings Against an Obesity Paradox"],"prefix":"10.2337","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5407-6874","authenticated-orcid":false,"given":"Jon","family":"Edqvist","sequence":"first","affiliation":[{"name":"Department of Molecular and Clinical Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden"},{"name":"Sahlgrenska University Hospital\/\u00d6stra, Gothenburg, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Araz","family":"Rawshani","sequence":"additional","affiliation":[{"name":"Department of Molecular and Clinical Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Adiels","sequence":"additional","affiliation":[{"name":"Health Metrics Unit, Sahlgrenska Academy, Gothenburg, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena","family":"Bj\u00f6rck","sequence":"additional","affiliation":[{"name":"Department of Molecular and Clinical Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden"},{"name":"Sahlgrenska University Hospital\/\u00d6stra, Gothenburg, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3796-9283","authenticated-orcid":false,"given":"Marcus","family":"Lind","sequence":"additional","affiliation":[{"name":"Department of Molecular and Clinical Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden"},{"name":"NU-Hospital Organisation, Uddevalla, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann-Marie","family":"Svensson","sequence":"additional","affiliation":[{"name":"Swedish National Diabetes Register, Centre of Registers, Gothenburg, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Gudbj\u00f6rnsdottir","sequence":"additional","affiliation":[{"name":"Swedish National Diabetes Register, Centre of Registers, Gothenburg, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1604-2593","authenticated-orcid":false,"given":"Naveed","family":"Sattar","sequence":"additional","affiliation":[{"name":"Institute of Cardiovascular and Medical Sciences, BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5409-6605","authenticated-orcid":false,"given":"Annika","family":"Rosengren","sequence":"additional","affiliation":[{"name":"Department of Molecular and Clinical Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden"},{"name":"Sahlgrenska University Hospital\/\u00d6stra, Gothenburg, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","published-online":{"date-parts":[[2019,5,2]]},"reference":[{"key":"2022031300542392200_B1","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.2337\/dc12-1693","article-title":"Use of the estimated glucose disposal rate as a measure of insulin resistance in an urban multiethnic population with type 1 diabetes","volume":"36","author":"Epstein","year":"2013","journal-title":"Diabetes Care"},{"key":"2022031300542392200_B2","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/eurheartj\/ehx448","article-title":"Separate and combined associations of obesity and metabolic health with coronary heart disease: a pan-European case-cohort analysis","volume":"39","author":"Lassale","year":"2018","journal-title":"Eur Heart J"},{"key":"2022031300542392200_B3","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1478-7954-10-22","article-title":"National, regional, and global trends in adult overweight and obesity prevalences","volume":"10","author":"Stevens","year":"2012","journal-title":"Popul Health Metr"},{"key":"2022031300542392200_B4","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/j.1464-5491.2010.02956.x","article-title":"Temporal patterns in overweight and obesity in Type 1 diabetes","volume":"27","author":"Conway","year":"2010","journal-title":"Diabet Med"},{"key":"2022031300542392200_B5","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1111\/j.1464-5491.2006.01901.x","article-title":"Mortality in African-Americans with type 1 diabetes: the New Jersey 725","volume":"23","author":"Roy","year":"2006","journal-title":"Diabet Med"},{"key":"2022031300542392200_B6","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/ijo.2009.75","article-title":"Adiposity and mortality in type 1 diabetes","volume":"33","author":"Conway","year":"2009","journal-title":"Int J Obes"},{"key":"2022031300542392200_B7","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.2337\/dc12-2007","article-title":"Relationship between overweight and obesity with hospitalization for heart failure in 20,985 patients with type 1 diabetes: a population-based study from the Swedish National Diabetes Registry","volume":"36","author":"Vestberg","year":"2013","journal-title":"Diabetes Care"},{"key":"2022031300542392200_B8","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1161\/CIRCULATIONAHA.117.028307","article-title":"Reverse causality in cardiovascular epidemiological research: more common than imagined","volume":"135","author":"Sattar","year":"2017","journal-title":"Circulation"},{"key":"2022031300542392200_B9","doi-asserted-by":"crossref","first-page":"996","DOI":"10.2337\/dc15-2450","article-title":"Association between use of lipid-lowering therapy and cardiovascular diseases and death in individuals with type 1 diabetes","volume":"39","author":"Hero","year":"2016","journal-title":"Diabetes Care"},{"key":"2022031300542392200_B10","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.2337\/dc10-0398","article-title":"Glycemic control and cardiovascular disease in 7,454 patients with type 1 diabetes: an observational study from the Swedish National Diabetes Register (NDR)","volume":"33","author":"Eeg-Olofsson","year":"2010","journal-title":"Diabetes Care"},{"key":"2022031300542392200_B11","doi-asserted-by":"crossref","first-page":"S291","DOI":"10.1016\/S0168-8227(14)70732-6","article-title":"Diabetes care\u2013improvement through measurement","volume":"106","author":"Eliasson","year":"2014","journal-title":"Diabetes Res Clin Pract"},{"key":"2022031300542392200_B12","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s10654-009-9350-y","article-title":"The Swedish personal identity number: possibilities and pitfalls in healthcare and medical research","volume":"24","author":"Ludvigsson","year":"2009","journal-title":"Eur J Epidemiol"},{"key":"2022031300542392200_B13","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1186\/1471-2458-11-450","article-title":"External review and validation of the Swedish national inpatient register","volume":"11","author":"Ludvigsson","year":"2011","journal-title":"BMC Public Health"},{"key":"2022031300542392200_B14","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.2337\/dc15-0145","article-title":"Impact of socioeconomic status on cardiovascular disease and mortality in 24,947 individuals with type 1 diabetes","volume":"38","author":"Rawshani","year":"2015","journal-title":"Diabetes Care"},{"key":"2022031300542392200_B15","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/S0140-6736(16)30054-X","article-title":"Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19\u00b72 million participants","volume":"387","author":"NCD Risk Factor Collaboration (NCD-RisC)","year":"2016","journal-title":"Lancet"},{"key":"2022031300542392200_B16","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1002\/oby.20602","article-title":"Does being overweight really reduce mortality","volume":"21","author":"Tobias","year":"2013","journal-title":"Obesity (Silver Spring)"},{"key":"2022031300542392200_B17","first-page":"1756","article-title":"Impact of excessive weight gain on cardiovascular outcomes in type 1 diabetes: results from the Diabetes Control and Complications Trial\/Epidemiology of Diabetes Interventions and Complications (DCCT\/EDIC) study","volume-title":"Diabetes Care","author":"Purnell","year":"2017"},{"key":"2022031300542392200_B18","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.clim.2013.04.006","article-title":"GLP-1 agonists in type 1 diabetes","volume":"149","author":"Pettus","year":"2013","journal-title":"Clin Immunol"},{"key":"2022031300542392200_B19","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.2337\/dc18-1749","article-title":"Empagliflozin as adjunctive to insulin therapy in type 1 diabetes: the EASE trials","volume":"41","author":"Rosenstock","year":"2018","journal-title":"Diabetes Care"},{"key":"2022031300542392200_B20","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1002\/oby.20992","article-title":"Bariatric surgery and diabetes: implications of type 1 versus insulin-requiring type 2","volume":"23","author":"Maraka","year":"2015","journal-title":"Obesity (Silver Spring)"},{"key":"2022031300542392200_B21","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1056\/NEJMoa1408214","article-title":"Glycemic control and excess mortality in type 1 diabetes","volume":"371","author":"Lind","year":"2014","journal-title":"N Engl J Med"},{"key":"2022031300542392200_B22","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/S2213-8587(15)00292-2","article-title":"Long-term excess risk of heart failure in people with type 1 diabetes: a prospective case-control study","volume":"3","author":"Rosengren","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2022031300542392200_B23","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1161\/CIRCULATIONAHA.116.025961","article-title":"Range of risk factor levels: control, mortality, and cardiovascular outcomes in type 1 diabetes mellitus","volume":"135","author":"Rawshani","year":"2017","journal-title":"Circulation"},{"key":"2022031300542392200_B24","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0140-6736(18)31506-X","article-title":"Excess mortality and cardiovascular disease in young adults with type 1 diabetes in relation to age at onset: a nationwide, register-based cohort study","volume":"392","author":"Rawshani","year":"2018","journal-title":"Lancet"},{"key":"2022031300542392200_B25","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.2337\/dc14-S014","article-title":"Standards of medical care in diabetes\u20142014","volume":"37","author":"American Diabetes Association","year":"2014","journal-title":"Diabetes Care"}],"container-title":["Diabetes Care"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/care.diabetesjournals.org\/syndication\/doi\/10.2337\/dc18-1446","content-type":"unspecified","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/42\/7\/1297\/530052\/dc181446.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/42\/7\/1297\/530052\/dc181446.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,13]],"date-time":"2022-03-13T04:25:31Z","timestamp":1647145531000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/care\/article\/42\/7\/1297\/36275\/BMI-Mortality-and-Cardiovascular-Outcomes-in-Type"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,2]]},"references-count":25,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2019,5,2]]},"published-print":{"date-parts":[[2019,7,1]]}},"URL":"https:\/\/doi.org\/10.2337\/dc18-1446","relation":{},"ISSN":["0149-5992","1935-5548"],"issn-type":[{"value":"0149-5992","type":"print"},{"value":"1935-5548","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,2]]}}}